Turning on T-cell death and turning off Crohn's disease

Safety of Bifidobacterium breve, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial.

Beneficial microbes·2022

Modulation, microbiota and inflammation in the adult CF gut: A prospective study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022

Metagenomic assembled plasmids of the human microbiome vary across disease cohorts.

Scientific reports·2022

Mapping the colorectal tumor microbiota.

Gut microbes·2021

The gut virome in Irritable Bowel Syndrome differs from that of controls.

Gut microbes·2021

The fecal mycobiome in patients with Irritable Bowel Syndrome.

Scientific reports·2021

The CA19-9 glycan is a viable target for CAR T cell therapy in pancreatic and other solid tumors.

Gastroenterology·2026

Fibroblast-derived Spondin-2 promotes dysplastic transition in metaplastic gastric epithelial cells.

Gastroenterology·2026

Global Prevalence of Celiac Disease and Clinical Characteristics in the General Population: A Systematic Review and Meta-Analysis.

Gastroenterology·2026

WNT-driven immune evasion promotes malignant transformation of BRAF-mutant colorectal cancer.

Gastroenterology·2026

WISP1 Drives Intestinal Fibrosis in Crohn's Disease via Metabolic and Rho/ROCK/MRTF-Mediated Cytoskeletal Remodeling.

Gastroenterology·2026

Identifying Patients With Prostate Cancer Who Benefit Most From Routine Cardiovascular Specialist Referral.

JACC. CardioOncology·2026

Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial.

Crohn's & colitis 360·2026

Unrecognized Charcot-Marie-Tooth Disease Unmasked by Chemotherapy-Induced Neurotoxicity.

Cureus·2026

Intraoperative Hemodynamic Management and Cerebral Protection During Awake Craniotomy: Evidence-Based Approaches.

Anesthesiology research and practice·2026

Combined Enzyme-Responsive Nano-Peptide Drug with Photothermal Function for Effective Anti-Hepatocellular Carcinoma in Mice Model.

International journal of nanomedicine·2026

Pathologic Complete Response to Neoadjuvant Dual Checkpoint Blockade with Durvalumab Plus Tremelimumab in Advanced-Stage HCC: A Case Report.

Journal of hepatocellular carcinoma·2026

Related Experiment Videos

Turning on T-cell death and turning off Crohn's disease

Related Concept Videos

Safety of Bifidobacterium breve, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial.

Modulation, microbiota and inflammation in the adult CF gut: A prospective study.

Metagenomic assembled plasmids of the human microbiome vary across disease cohorts.

Mapping the colorectal tumor microbiota.

The gut virome in Irritable Bowel Syndrome differs from that of controls.

The fecal mycobiome in patients with Irritable Bowel Syndrome.

The CA19-9 glycan is a viable target for CAR T cell therapy in pancreatic and other solid tumors.

Fibroblast-derived Spondin-2 promotes dysplastic transition in metaplastic gastric epithelial cells.

Global Prevalence of Celiac Disease and Clinical Characteristics in the General Population: A Systematic Review and Meta-Analysis.

WNT-driven immune evasion promotes malignant transformation of BRAF-mutant colorectal cancer.

WISP1 Drives Intestinal Fibrosis in Crohn's Disease via Metabolic and Rho/ROCK/MRTF-Mediated Cytoskeletal Remodeling.

Identifying Patients With Prostate Cancer Who Benefit Most From Routine Cardiovascular Specialist Referral.

Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial.

Unrecognized Charcot-Marie-Tooth Disease Unmasked by Chemotherapy-Induced Neurotoxicity.

Intraoperative Hemodynamic Management and Cerebral Protection During Awake Craniotomy: Evidence-Based Approaches.

Combined Enzyme-Responsive Nano-Peptide Drug with Photothermal Function for Effective Anti-Hepatocellular Carcinoma in Mice Model.

Pathologic Complete Response to Neoadjuvant Dual Checkpoint Blockade with Durvalumab Plus Tremelimumab in Advanced-Stage HCC: A Case Report.

Related Experiment Videos

Turning on T-cell death and turning off Crohn's disease

Related Concept Videos

Related Articles